Practical methods for Hong Kong stock market influencers to participate in new stock offerings.

    812 viewsAug 19, 2025
    playBtn

    New analysis of Zhaoke ophthalmology

    Recently, a new medicine B stock, Mega Ophthalmology, has been added. Many people don't know what to think of this unprofitable pharmaceutical stock.

    In the eyes of old and new drivers like me who have not lost money on playing new medicine B, even if there is no professional knowledge, in fact, there are still traces to follow, three axes to deal with. Of course, non-professional advice is for reference only.

    $Mega Ophthalmology-B (06622.HK) $ $Ojai Vision Biology-B (01477.HK) $ $Xingqi Eye pills (300573.SZ) $

    Disclaimer: The above content does not constitute any act of financial product marketing, investment offer, or financial advice. Before making any investment decision, investors should consider the risk factors related to investment products based on their own circumstances and consult professional investment advisors where necessary.

    Recommended

      Market Insights
      HK Tech and Internet Stocks
      View More
      Nancy Pelosi Portfolio
      Hot Topics
      Will the 'tariff stick' strike again? Will the market remain 'reactive'?
      China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More